B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 625 KRW 2.78% Market Closed
Market Cap: 471.7B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioNote Inc
Total Liabilities & Equity Peer Comparison

Comparables:
068270
302440
H
145020
P
214450
196170

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Total Liabilities & Equity
â‚©1.6T
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Total Liabilities & Equity
â‚©19.9T
CAGR 3-Years
56%
CAGR 5-Years
40%
CAGR 10-Years
24%
SK Bioscience Co Ltd
KRX:302440
Total Liabilities & Equity
â‚©1.9T
CAGR 3-Years
49%
CAGR 5-Years
36%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Total Liabilities & Equity
â‚©899.4B
CAGR 3-Years
-3%
CAGR 5-Years
0%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Total Liabilities & Equity
â‚©601.5B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Total Liabilities & Equity
â‚©306.3B
CAGR 3-Years
6%
CAGR 5-Years
33%
CAGR 10-Years
N/A

See Also

What is BioNote Inc's Total Liabilities & Equity?
Total Liabilities & Equity
1.6T KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Total Liabilities & Equity amounts to 1.6T KRW.

What is BioNote Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
23%

Over the last year, the Total Liabilities & Equity growth was -9%. The average annual Total Liabilities & Equity growth rates for BioNote Inc have been 23% over the past three years .

Back to Top